43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 15
00:24 UTC
|
AYA
Aya Gold & Silver
|
◎ Target | firm only | C$35.00→ C$41.50+18.6% | |
|
Aug 15
00:24 UTC
|
AYA
Aya Gold & Silver
|
◎ Target | firm only | C$36.00→ C$41.00+13.9% | |
|
Aug 15
00:24 UTC
|
AVAH
Aveanna Healthcare
|
◎ Target | Sean Dodge ★★★★☆ #447 | Outperform | $10.00→ $14.00+40.0% |
|
Aug 15
00:24 UTC
|
AVAH
Aveanna Healthcare
|
◎ Target | A.J. Rice ★★★★★ #322 | Neutral | $8.00→ $13.00+62.5% |
|
Aug 15
00:24 UTC
|
AVAH
Aveanna Healthcare
|
◎ Target | John Ransom ★★★★★ #119 | Strong-Buy | $13.00→ $15.00+15.4% |
|
Aug 15
00:24 UTC
|
ASND
Ascendis Pharma A/S
|
◎ Target | Yaron Werber ★★★☆☆ #2161 | Buy | $325.00→ $341.00+4.9% |
|
Aug 15
00:24 UTC
|
ASND
Ascendis Pharma A/S
|
◎ Target | Luca Issi ★★★☆☆ #1921 | Outperform | $280.00→ $290.00+3.6% |
|
Aug 15
00:24 UTC
|
ASND
Ascendis Pharma A/S
|
◎ Target | Eliana Merle ★★★☆☆ #1396 | Overweight | $345.00→ $329.00-4.6% |
|
Aug 15
00:24 UTC
|
APPN
Appian
|
◎ Target | Lucky Schreiner ★★★★☆ #547 | Neutral | $34.00→ $42.00+23.5% |
|
Aug 15
00:24 UTC
|
API
Agora
|
◎ Target | Daley Li ★★☆☆☆ #2814 | Buy | $6.60→ $6.80+3.0% |
|
Aug 15
00:24 UTC
|
ANTO
Antofagasta
|
◎ Target | firm only | Overweight | GBX 4,500→ GBX 4,300-4.4% |
|
Aug 15
00:24 UTC
|
AMN
AMN Healthcare Services
|
◎ Target | Constantine Davides ★★☆☆☆ #2572 | Market Outperform | $36.00→ $40.00+11.1% |
|
Aug 15
00:24 UTC
|
AMGN
Amgen
|
◎ Target | Emily Field ★★★★☆ #837 | Equal Weight | $360.00→ $380.00+5.6% |
|
Aug 15
00:24 UTC
|
AMCR
Amcor
|
◎ Target | Gabe Hajde not yet tracked | Equal Weight | $43.00→ $44.00+2.3% |
|
Aug 15
00:24 UTC
|
AMAT
Applied Materials
|
◎ Target | Christian Schwab ★★☆☆☆ #2580 | Buy | $530.00→ $585.00+10.4% |
|
Aug 15
00:24 UTC
|
AMAT
Applied Materials
|
◎ Target | Stacy Rasgon ★★★☆☆ #1629 | Outperform | $675.00→ $700.00+3.7% |
|
Aug 15
00:24 UTC
|
AMAT
Applied Materials
|
◎ Target | Shane Brett not yet tracked | Equal Weight | $646.00→ $642.00-0.6% |
|
Aug 15
00:24 UTC
|
AMAT
Applied Materials
|
◎ Target | Timothy Arcuri ★★☆☆☆ #2503 | Buy | $705.00→ $675.00-4.3% |
|
Aug 15
00:24 UTC
|
AMAT
Applied Materials
|
◎ Target | Vivek Arya ★★☆☆☆ #2893 | Buy | $720.00→ $650.00-9.7% |
|
Aug 15
00:24 UTC
|
AMAT
Applied Materials
|
◎ Target | Harlan Sur ★★☆☆☆ #2333 | Overweight | $515.00→ $660.00+28.2% |
|
Aug 15
00:24 UTC
|
AMAT
Applied Materials
|
◎ Target | Srini Pajjuri ★★☆☆☆ #2416 | Outperform | $520.00→ $600.00+15.4% |
|
Aug 15
00:24 UTC
|
ALNY
Alnylam Pharmaceuticals
|
◎ Target | Derek Archila ★★☆☆☆ #2285 | Equal Weight | $316.00→ $256.00-19.0% |
|
Aug 15
00:24 UTC
|
ALH
Alliance Laundry
|
◎ Target | Tomohiko Sano ★★☆☆☆ #2652 | Overweight | $31.00→ $32.00+3.2% |
|
Aug 15
00:24 UTC
|
ALH
Alliance Laundry
|
◎ Target | Michael Halloran ★★★☆☆ #1663 | Outperform | $32.00→ $34.00+6.2% |
|
Aug 15
00:24 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Brett Linzey ★★★☆☆ #2090 | Outperform | $355.00→ $400.00+12.7% |
|
Aug 15
00:24 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | David Manthey ★★★☆☆ #1708 | Outperform | $317.00→ $400.00+26.2% |
|
Aug 15
00:24 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Chris Dankert ★★★☆☆ #1332 | Buy | $380.00→ $400.00+5.3% |
|
Aug 15
00:24 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Ken Newman not yet tracked | Overweight | $375.00→ $420.00+12.0% |
|
Aug 15
00:24 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Sabrina Abrams not yet tracked | Buy | $380.00→ $390.00+2.6% |
|
Aug 15
00:24 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Christopher Glynn ★★★☆☆ #1763 | Outperform | $350.00→ $390.00+11.4% |
|
Aug 15
00:24 UTC
|
AHR
American Healthcare REIT
|
◎ Target | Michael Lewis ★★★★☆ #800 | Buy | $57.00→ $61.00+7.0% |
|
Aug 15
00:24 UTC
|
AHR
American Healthcare REIT
|
◎ Target | Michael Carroll ★★★★☆ #692 | Outperform | $56.00→ $61.00+8.9% |
|
Aug 15
00:24 UTC
|
AEBI
Aebi Schmidt
|
◎ Target | Michael Shlisky ★★☆☆☆ #2837 | Buy | $15.00→ $17.00+13.3% |
|
Aug 15
00:24 UTC
|
ADEA
Adeia
|
◎ Target | Hamed Khorsand ★★☆☆☆ #2856 | Buy | $30.00→ $50.00+66.7% |
|
Aug 15
00:24 UTC
|
ACQ
AutoCanada
|
◎ Target | firm only | C$24.00→ C$27.00+12.5% | |
|
Aug 15
00:24 UTC
|
ACM
AECOM
|
◎ Target | Andrew Wittmann ★★★★☆ #568 | Neutral | $73.00→ $65.00-11.0% |
|
Aug 15
00:24 UTC
|
AC
Air Canada
|
◎ Target | firm only | C$26.00→ C$40.00+53.8% | |
|
Aug 15
00:24 UTC
|
AADX
Applied Aerospace & Defense
|
◎ Target | Ronald Epstein ★★☆☆☆ #2456 | Buy | $24.00→ $23.00-4.2% |
|
Aug 14
21:23 UTC
|
TGT
Target
|
◎ Target | Joseph Feldman not yet tracked | Outperform | $150.00→ $170.00+13.3% |
|
Aug 14
21:23 UTC
|
SRTS
Sensus Healthcare
|
◎ Target | Ben Haynor ★★☆☆☆ #2840 | Buy | $4.50→ $4.00-11.1% |
|
Aug 14
21:23 UTC
|
ROST
Ross Stores
|
◎ Target | Dana Telsey ★★★☆☆ #1047 | Outperform | $265.00→ $280.00+5.7% |
|
Aug 14
21:23 UTC
|
LSF
Laird Superfood
|
◎ Target | Anthony Vendetti ★☆☆☆☆ #3197 | Buy | $6.00→ $10.00+66.7% |
|
Aug 14
21:23 UTC
|
HIT
Health In Tech
|
◎ Target | Allen Klee ★☆☆☆☆ #3160 | Buy | $4.00→ $3.00-25.0% |
|
Aug 14
21:23 UTC
|
HGBL
Heritage Global
|
◎ Target | Jacob Stephen not yet tracked | Buy | $4.50→ $3.00-33.3% |
|
Aug 14
21:23 UTC
|
CLBT
Cellebrite DI
|
◎ Target | Eric Martinuzzi ★★★☆☆ #1594 | Buy | $21.00→ $15.00-28.6% |
|
Aug 14
21:23 UTC
|
BIRK
Birkenstock
|
◎ Target | Dana Telsey ★★★☆☆ #1047 | Outperform | $45.00→ $50.00+11.1% |
|
Aug 14
20:23 UTC
|
KOPN
Kopin
|
◎ Target | Austin Moeller ★☆☆☆☆ #3175 | Buy | $6.25→ $6.50+4.0% |
|
Aug 14
20:23 UTC
|
HTFL
Heartflow
|
◎ Target | William Plovanic ★★★★☆ #570 | Buy | $37.00→ $45.00+21.6% |
|
Aug 14
20:23 UTC
|
ETON
Eton Pharmaceuticals
|
◎ Target | Gary Nachman ★★★☆☆ #1222 | Buy | $60.00→ $68.00+13.3% |
|
Aug 14
20:23 UTC
|
ENVX
Enovix
|
◎ Target | George Gianarikas ★☆☆☆☆ #3221 | Buy | $15.00→ $10.00-33.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.